0001104659-23-129255.txt : 20231226
0001104659-23-129255.hdr.sgml : 20231226
20231226170807
ACCESSION NUMBER: 0001104659-23-129255
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231221
FILED AS OF DATE: 20231226
DATE AS OF CHANGE: 20231226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bernstein Bruce
CENTRAL INDEX KEY: 0001665472
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39752
FILM NUMBER: 231513945
MAIL ADDRESS:
STREET 1: 780 THIRD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815903
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851410058
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 973-242-0005
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
tm2333705-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-21
0
0001815903
Petros Pharmaceuticals, Inc.
PTPI
0001665472
Bernstein Bruce
C/O PETROS PHARMACEUTICALS, INC.
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
1
0
0
0
0
Stock Option (Right to Buy)
1.41
2023-12-21
4
A
0
40000
0
A
2033-12-21
Common Stock
40000
40000
D
The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date.
/s/ Mitchell Arnold, attorney-in-fact
2023-12-26